Literature DB >> 24848528

Vertical rectus abdominis myocutaneous flap and quality of life following abdominoperineal excision for rectal cancer: a multi-institutional study.

V O'Dowd1, J P Burke, E Condon, D Waldron, N Ajmal, J Deasy, D A McNamara, J C Coffey.   

Abstract

BACKGROUND: To obtain a clear surgical margin, abdominoperineal excision (APE) for rectal cancer frequently leaves a large perineal defect surrounded by irradiated tissue. A vertical rectus abdominis myocutaneous (VRAM) flap may facilitate healing of this wound. The current study aims to determine the effect of VRAM flap perineal reconstruction following APE on patient quality of life (QOL).
METHODS: This is a retrospective cohort study from a prospectively collected database. Data on QOL were assessed via telephone questionnaire using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)-C30, EORTC QLQ-C29 and the Cleveland Clinic QOL questionnaires.
RESULTS: Twenty-seven patients underwent primary perineal closure, and 12 patients underwent a VRAM flap perineal reconstruction. The mean duration of follow-up was 16.8 months. Overall, there was no significant difference in the Cleveland Clinic QOL score between groups (VRAM vs. no VRAM: 0.7 ± 0.2 vs. 0.7 ± 0.2, p 0.735). Patients in the VRAM group had lower levels of fatigue (5.5 ± 9.9 vs. 23.6 ± 19.2, p 0.004). Patients in the VRAM group had reduced sore skin scores around the stoma site (11.0 ± 16.2 vs. 31.8 ± 31.1, p 0.036). VRAM flap was associated with an increased incidence of abdominal wall hernia (VRAM vs. no VRAM: 25 % vs. 0 %, p 0.024).
CONCLUSIONS: This study is limited by its non-randomized retrospective design and relatively small sample size. A significant difference in patient QOL was not demonstrated between VRAM flap and primary perineal closure after APE for rectal cancer. Further studies in this area are warranted.

Entities:  

Mesh:

Year:  2014        PMID: 24848528     DOI: 10.1007/s10151-014-1156-6

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  27 in total

1.  Perineal hernia after proctectomy: prevalence, risks, and management.

Authors:  E Aboian; D C Winter; D R Metcalf; B G Wolff
Journal:  Dis Colon Rectum       Date:  2006-10       Impact factor: 4.585

2.  Pelvic reconstruction after abdominoperineal resection: is it worthwhile?

Authors:  Charles E Butler; Miguel A Rodriguez-Bigas
Journal:  Ann Surg Oncol       Date:  2005-02-04       Impact factor: 5.344

3.  Utility of the omentum in pelvic floor reconstruction following resection of anorectal malignancy: patient selection, technical caveats, and clinical outcomes.

Authors:  Charles S Hultman; Matthew A Sherrill; Eric G Halvorson; Clara N Lee; John F Boggess; Michael O Meyers; Benjamin A Calvo; Hong J Kim
Journal:  Ann Plast Surg       Date:  2010-05       Impact factor: 1.539

4.  Early outcomes for rectal cancer surgery in the republic of ireland following a national centralization program.

Authors:  John P Burke; J Calvin Coffey; Emily Boyle; Frank Keane; Deborah A McNamara
Journal:  Ann Surg Oncol       Date:  2013-08-02       Impact factor: 5.344

5.  Perineal repair after extralevator abdominoperineal excision for low rectal cancer.

Authors:  Henrik Kidmose Christensen; Peter Nerstrøm; Troels Tei; Søren Laurberg
Journal:  Dis Colon Rectum       Date:  2011-06       Impact factor: 4.585

Review 6.  Reconstruction of the perineum following extralevator abdominoperineal excision for carcinoma of the lower rectum: a systematic review.

Authors:  J D Foster; S Pathak; N J Smart; G Branagan; R J Longman; M G Thomas; N Francis
Journal:  Colorectal Dis       Date:  2012-09       Impact factor: 3.788

7.  Outcomes of immediate vertical rectus abdominis myocutaneous flap reconstruction for irradiated abdominoperineal resection defects.

Authors:  Charles E Butler; A Ozlem Gündeslioglu; Miguel A Rodriguez-Bigas
Journal:  J Am Coll Surg       Date:  2008-02-11       Impact factor: 6.113

8.  Vertical rectus abdominis myocutaneous flap reconstruction of the perineal defect after abdominoperineal excision is associated with low morbidity.

Authors:  T Barker; G Branagan; E Wright; A Crick; C McGuiness; H Chave
Journal:  Colorectal Dis       Date:  2013-09       Impact factor: 3.788

9.  An algorithmic approach to perineal reconstruction after cancer resection--experience from two international centers.

Authors:  Hannah Eliza John; Zita Maria Jessop; Michele Di Candia; Jeremy Simcock; Amer J Durrani; Charles M Malata
Journal:  Ann Plast Surg       Date:  2013-07       Impact factor: 1.539

10.  The impact of the Calman-Hine report on the processes and outcomes of care for Yorkshire's colorectal cancer patients.

Authors:  E Morris; R A Haward; M S Gilthorpe; C Craigs; D Forman
Journal:  Br J Cancer       Date:  2006-10-23       Impact factor: 7.640

View more
  4 in total

1.  Abdominoperineal resection and perineal wound healing in recurrent, persistent, or primary anal carcinoma.

Authors:  J Hardt; S Mai; C Weiß; Peter Kienle; J Magdeburg
Journal:  Int J Colorectal Dis       Date:  2016-03-31       Impact factor: 2.571

2.  Time to Chemotherapy After Abdominoperineal Resection: Comparison Between Primary Closure and Perineal Flap Reconstruction.

Authors:  Azah A Althumairi; Joseph K Canner; Nita Ahuja; Justin M Sacks; Bashar Safar; Jonathan E Efron
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

3.  Pelvic/Perineal Reconstruction: Time to Consider the Anterolateral Thigh Flap as a First-line Option?

Authors:  David Perrault; Cindy Kin; Derrick C Wan; Natalie Kirilcuk; Andrew Shelton; Arash Momeni
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-04-24

Review 4.  Perineal Wound Closure Following Abdominoperineal Resection and Pelvic Exenteration for Cancer: A Systematic Review and Meta-Analysis.

Authors:  Etienne Buscail; Cindy Canivet; Jason Shourick; Elodie Chantalat; Nicolas Carrere; Jean-Pierre Duffas; Antoine Philis; Emilie Berard; Louis Buscail; Laurent Ghouti; Benoit Chaput
Journal:  Cancers (Basel)       Date:  2021-02-10       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.